Acadia Healthcare Shares Tumble After Q3 Revenue Miss, 2024 Guidance Cut

MT Newswires Live11-01

Acadia Healthcare (ACHC) shares were down over 16% in recent Thursday trading, a day after it posted lower-than-expected Q3 revenue and trimmed its full-year 2024 guidance to levels below analyst estimates.

The company reported Q3 adjusted earnings late Wednesday of $0.91 per diluted share, unchanged from a year earlier. Analysts polled by Capital IQ expected $0.90.

Revenue for the quarter ended Sept. 30 was $815.6 million, up from $750.3 million a year earlier. Analysts polled by Capital IQ expected $819.5 million.

The company said it now expects full-year 2024 adjusted EPS of $3.35 to $3.45, compared with the prior range of $3.45 and $3.65. Analysts expect $3.49.

Revenue for the full year is now expected at between $3.15 billion and $3.17 billion, versus the company's prior outlook of $3.18 billion to $3.23 billion. Analysts are looking for $3.19 billion.

Price: 43.48, Change: -8.60, Percent Change: -16.51

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment